Open: 0.0 Close: 0.0 Change: 0.0

Today's Summary

guardant health to present 28 abstracts highlighting advances in tumor typing, therapy selection and expanded utility of multiomic tissue and liquid biopsy testing at aacr 2026 | nasdaq. key data that will be presented include: an oral presentation of research data showing high accuracy of Guardant360 Tissue in determining tissue of origin with strong performance. other factors be weighing on sentiment include Home prices, health care costs, Ukraine War,